スピルリナ市場:タイプ別(Arthrospira Platensis、Arthrospira Maxima)、用途別(栄養補助食品、食品・飲料、化粧品、動物飼料、その他)、製剤別(粉末、錠剤・カプセル、液体、顆粒・ゲル化剤):2027年までの世界の機会分析と産業予測Spirulina Market by Type (Arthrospira Platensis and Arthrospira Maxima), Application (Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others), and Formulation (Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent): Global Opportunity Analysis and Industry Forecast up to 2027 スピルリナ市場とは、スピルリナとして知られる藍藻類の市場を指す。スピルリナは天然の栄養補助食品であり、その栄養価と潜在的な健康効果が広く認められている。それは、タンパク質、ビタミン、ミネラル、抗酸... もっと見る
サマリースピルリナ市場とは、スピルリナとして知られる藍藻類の市場を指す。スピルリナは天然の栄養補助食品であり、その栄養価と潜在的な健康効果が広く認められている。それは、タンパク質、ビタミン、ミネラル、抗酸化物質、および他の生物活性化合物の豊富な源である。スピルリナの健康上の利点についての意識の高まりは、その市場成長のための主要な要因となっている。スピルリナは、それが健康志向の消費者の間で人気の選択肢を作り、必須栄養素、ビタミン、ミネラル、抗酸化物質が豊富である。免疫力を高め、消化を改善し、体重管理をサポートする上でその潜在的な利点は、スピルリナの需要を煽っている。一方、汚染の可能性がスピルリナ市場の成長を制限する可能性があります。スピルリナ市場は、2027年までに年平均成長率4.8%で成長する可能性が高い。タイプ別スピルリナ市場 Arthrospira Platensis Arthrospira Maxima 用途別スピルリナ市場 栄養補助食品 食品・飲料 化粧品 動物飼料 ルート製剤別スピルリナ市場 粉末 錠剤・カプセル 液体 顆粒・ゲル化剤 スピルリナ市場:地域別 北米 ヨーロッパ アジア太平洋 その他の地域 以下は、スピルリナ市場の主要な側面の概要である: 栄養補助食品:栄養補助食品:スピルリナは、その高い栄養含有量により、栄養補助食品として消費されることが多い。それは植物ベースのタンパク質源としてベジタリアンやビーガンの間で人気の選択肢になり、そのタンパク質含量のために特に知られている。スピルリナはまた、必須アミノ酸、ビタミン(ビタミンB群やビタミンKなど)、ミネラル(鉄、マグネシウム、カルシウムなど)、抗酸化物質(フィコシアニンやベータカロチンなど)を含んでいます。 健康上の利点:スピルリナは、いくつかの健康上の利点を提供すると考えられている。免疫力を高めたり、コレステロール値を下げて心臓の健康をサポートしたり、抗炎症作用や抗酸化作用をもたらしたりする可能性がある。スピルリナはまた、体重管理、腸内環境の改善、健康的な血糖値をサポートする役割の可能性についても研究されている。しかし、その効果と作用機序を完全に理解するには、さらなる研究が必要である。 形態と製品:スピルリナは、粉末、錠剤、カプセル、フレークなど様々な形態で利用可能です。そのまま摂取することも、スムージーやジュース、食品に混ぜて摂取することもできる。スピルリナは、栄養補助食品、機能性食品、飲料、家畜飼料の製造に使用されている。 栽培と生産スピルリナは淡水または海水の環境で培養される。通常、大規模な商業施設や、池や水槽のような管理された環境で栽培される。スピルリナの生産には、藻の培養、収穫、乾燥、消費またはさらなる使用のための所望の形態への加工が含まれる。 市場の成長:スピルリナ市場は、その栄養的利点に対する消費者の意識の高まりと、天然素材や植物由来素材への需要の高まりによって、近年著しい成長を遂げている。ベジタリアンやビーガン食の人気の高まりや、健康とウェルネスへの関心の高まりが、市場の拡大に寄与している。また、スピルリナは従来の家畜生産に比べ環境負荷の少ない持続可能なタンパク質源としても注目を集めている。 規制と品質管理:スピルリナに対する需要の高まりを受けて、規制当局は製品の安全性と品質を確保するための基準やガイドラインを設けている。製造業者はこれらの規制を遵守し、スピルリナ製品の完全性と純度を維持するために適正製造規範に従うことが重要である。 スピルリナ市場の主な大手企業は、アルジェノールバイオ燃料株式会社、Cabassi&Giuriatiスパ、シアノテック株式会社、Ddw株式会社、Dic株式会社、Döhler Gmbh、Dongtai市スピルリナバイオエンジニアリング株式会社、Echlorial、E.I.D.パリーリミテッド、ジボダンインターナショナルSa、ProlgaeスピルリナサプライPvt.株式会社、ポンド-テクノロジーズ-インク、センシエント-テクノロジーズ-コーポレーションです。 同市場は競争が激しく、各社は製品の品質、技術革新、マーケティング戦略に注力し、消費者需要の拡大を取り込もうとしている。 スピルリナは、一般的にほとんどの人にとって安全であると考えられているが、それはすべての人に適していない可能性があることは注目に値する。それは、新しい栄養補助食品を開始したり、あなたの食事に大きな変更を加える前に、医療専門家に相談することをお勧めします。 すべての主要な地理的地域の排他的な分析は、これらの地域における潜在的な機会を決定するレポートに含まれています。 予測期間におけるスピルリナ市場の成長を生み出している属性に関する詳細情報。 スピルリナ市場シェアと親市場への貢献の正確な推定は、報告書で提供されています。 主要な競合他社のさらなるプロフィールとそのダイナミックな戦略も、この調査でカバーされています。 目次1. Executive Summary2. Industry Outlook 2.1. Industry Overview 2.2. Industry Trends 3. Market Snapshot 3.1. Market Definition 3.2. Market Outlook 3.2.1. Porter Five Forces 3.3. Related Markets 4. Market characteristics 4.1. Market Overview 4.2. Market Segmentation 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. DRO - Impact Analysis 5. Type: Market Size & Analysis 5.1. Overview 5.2. Arthrospira Platensis 5.3. Arthrospira Maxima 6. Application: Market Size & Analysis 6.1. Overview 6.2. Nutraceuticals 6.3. Food & Beverages 6.4. Cosmetics 6.5. Animal Feed 7. Distribution Channel: Market Size & Analysis 7.1. Overview 7.2. Hospital Pharmacies 7.3. Online Providers 7.4. Drug Stores and Retail Pharmacies 8. Geography: Market Size & Analysis 8.1. Overview 8.2. North America 8.3. Europe 8.4. Asia Pacific 8.5. Rest of the World 9. Competitive Landscape 9.1. Competitor Comparison Analysis 9.2. Market Developments 9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships 9.2.2. Product Launches and execution 10. Vendor Profiles 10.1. Algenol Biofuels Inc. 10.1.1. Overview 10.1.2. Financial Overview 10.1.3. Product Offerings 10.1.4. Developments 10.1.5. Business Strategy 10.2. Cabassi & Giuriati Spa 10.2.1. Overview 10.2.2. Financial Overview 10.2.3. Product Offerings 10.2.4. Developments 10.2.5. Business Strategy 10.3. Cyanotech Corporation 10.3.1. Overview 10.3.2. Financial Overview 10.3.3. Product Offerings 10.3.4. Developments 10.3.5. Business Strategy 10.4. Ddw Inc. 10.4.1. Overview 10.4.2. Financial Overview 10.4.3. Product Offerings 10.4.4. Developments 10.4.5. Business Strategy 10.5. Dic Corporation 10.5.1. Overview 10.5.2. Financial Overview 10.5.3. Product Offerings 10.5.4. Developments 10.5.5. Business Strategy 10.6. Döhler Gmbh 10.6.1. Overview 10.6.2. Financial Overview 10.6.3. Product Offerings 10.6.4. Developments 10.6.5. Business Strategy 10.7. Dongtai City Spirulina Bio-Engineering Co, Ltd. 10.7.1. Overview 10.7.2. Financial Overview 10.7.3. Product Offerings 10.7.4. Developments 10.7.5. Business Strategy 10.8. Echlorial 10.8.1. Overview 10.8.2. Financial Overview 10.8.3. Product Offerings 10.8.4. Developments 10.8.5. Business Strategy 10.9. E.I.D. Parry Limited 10.9.1. Overview 10.9.2. Financial Overview 10.9.3. Product Offerings 10.9.4. Developments 10.9.5. Business Strategy 10.10. Givaudan International Sa 10.10.1. Overview 10.10.2. Financial Overview 10.10.3. Product Offerings 10.10.4. Developments 10.10.5. Business Strategy 10.11. Prolgae Spirulina Supplies Pvt. Ltd. 10.11.1. Overview 10.11.2. Financial Overview 10.11.3. Product Offerings 10.11.4. Developments 10.11.5. Business Strategy 10.12. Pond Technologies Inc. 10.12.1. Overview 10.12.2. Financial Overview 10.12.3. Product Offerings 10.12.4. Developments 10.12.5. Business Strategy 10.13. Sensient Technologies Corporation 10.13.1. Overview 10.13.2. Financial Overview 10.13.3. Product Offerings 10.13.4. Developments 10.13.5. Business Strategy 11. Analyst Opinion 12. Annexure 12.1. Report Scope 12.2. Market Definitions 12.3. Research Methodology 12.3.1. Data Collation and In-house Estimation 12.3.2. Market Triangulation 12.3.3. Forecasting 12.4. Report Assumptions 12.5. Declarations 12.6. Stakeholders 12.7. Abbreviations 図表リストTABLE 1. GLOBAL SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)TABLE 2. GLOBAL SPIRULINA MARKET VALUE FOR ARTHROSPIRA PLATENSIS, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 3. GLOBAL SPIRULINA MARKET VALUE FOR ARTHROSPIRA MAXIMA, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 4. GLOBAL SPIRULINA MARKET VALUE, BY APPLICATION, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 5. GLOBAL SPIRULINA MARKET VALUE FOR NUTRACEUTICALS, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 6. GLOBAL SPIRULINA MARKET VALUE FOR FOOD & BEVERAGES, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 7. GLOBAL SPIRULINA MARKET VALUE FOR COSMETICS, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 8. GLOBAL SPIRULINA MARKET VALUE FOR ANIMAL FEED, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 9. GLOBAL SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 10. GLOBAL SPIRULINA MARKET VALUE FOR POWDER, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 11. GLOBAL SPIRULINA MARKET VALUE FOR TABLET & CAPSULE, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 12. GLOBAL SPIRULINA MARKET VALUE FOR LIQUID, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 13. GLOBAL SPIRULINA MARKET VALUE FOR GRANULE & GELLING AGENT, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 14. NORTH AMERICA SPIRULINA MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION) TABLE 15. NORTH AMERICA SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 16. NORTH AMERICA SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 17. NORTH AMERICA SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 18. U.S SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 19. U.S SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 20. U.S SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 21. CANADA SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 22. CANADA SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 23. CANADA SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 24. EUROPE SPIRULINA MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION) TABLE 25. EUROPE SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 26. EUROPE SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 27. EUROPE SPIRULINA MARKET VALUE, ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 28. GERMANY SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 29. GERMANY SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 30. GERMANY SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 31. U.K SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 32. U.K SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 33. U.K SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 34. FRANCE SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 35. FRANCE SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 36. FRANCE SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 37. ITALY SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 38. ITALY SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 39. ITALY SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 40. SPAIN SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 41. SPAIN SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 42. SPAIN SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 43. ROE SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 44. ROE SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 45. ROE SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 46. ASIA PACIFC SPIRULINA MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION) TABLE 47. ASIA PACIFC SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 48. ASIA PACIFC SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 49. ASIA PACIFC SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 50. CHINA SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 51. CHINA SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 52. CHINA SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 53. INDIA SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 54. INDIA SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 55. INDIA SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 56. JAPAN SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 57. JAPAN SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 58. JAPAN SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 59. REST OF APAC SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 60. REST OF APAC SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 61. REST OF APAC SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 62. REST OF WORLD SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 63. REST OF WORLD SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 64. REST OF WORLD SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 65. ALGENOL BIOFUELS INC.: FINANCIALS TABLE 66. ALGENOL BIOFUELS INC.: PRODUCTS & SERVICES TABLE 67. ALGENOL BIOFUELS INC.: RECENT DEVELOPMENTS TABLE 68. CABASSI & GIURIATI SPA: FINANCIALS TABLE 69. CABASSI & GIURIATI SPA: PRODUCTS & SERVICES TABLE 70. CABASSI & GIURIATI SPA: RECENT DEVELOPMENTS TABLE 71. CYANOTECH CORPORATION: FINANCIALS TABLE 72. CYANOTECH CORPORATION: PRODUCTS & SERVICES TABLE 73. CYANOTECH CORPORATION: RECENT DEVELOPMENTS TABLE 74. DDW INC.: FINANCIALS TABLE 75. DDW INC.: PRODUCTS & SERVICES TABLE 76. DDW INC.: RECENT DEVELOPMENTS TABLE 77. DIC CORPORATION: FINANCIALS TABLE 78. DIC CORPORATION: PRODUCTS & SERVICES TABLE 79. DIC CORPORATION: RECENT DEVELOPMENTS TABLE 80. DÖHLER GMBH: FINANCIALS TABLE 81. DÖHLER GMBH: PRODUCTS & SERVICES TABLE 82. DÖHLER GMBH: RECENT DEVELOPMENTS TABLE 83. DONGTAI CITY SPIRULINA BIO-ENGINEERING CO, LTD.: FINANCIALS TABLE 84. DONGTAI CITY SPIRULINA BIO-ENGINEERING CO, LTD.: PRODUCTS & SERVICES TABLE 85. DONGTAI CITY SPIRULINA BIO-ENGINEERING CO, LTD.: RECENT DEVELOPMENTS TABLE 86. ECHLORIAL: FINANCIALS TABLE 87. ECHLORIAL: PRODUCTS & SERVICES TABLE 88. ECHLORIAL: RECENT DEVELOPMENTS TABLE 89. E.I.D. PARRY LIMITED: FINANCIALS TABLE 90. E.I.D. PARRY LIMITED: PRODUCTS & SERVICES TABLE 91. E.I.D. PARRY LIMITED: RECENT DEVELOPMENTS TABLE 92. GIVAUDAN INTERNATIONAL SA: FINANCIALS TABLE 93. GIVAUDAN INTERNATIONAL SA: PRODUCTS & SERVICES TABLE 94. GIVAUDAN INTERNATIONAL SA: RECENT DEVELOPMENTS TABLE 95. PROLGAE SPIRULINA SUPPLIES PVT. LTD.: FINANCIALS TABLE 96. PROLGAE SPIRULINA SUPPLIES PVT. LTD.: PRODUCTS & SERVICES TABLE 97. PROLGAE SPIRULINA SUPPLIES PVT. LTD.: RECENT DEVELOPMENTS TABLE 98. POND TECHNOLOGIES INC.: FINANCIALS TABLE 99. POND TECHNOLOGIES INC.: PRODUCTS & SERVICES TABLE 100. POND TECHNOLOGIES INC.: RECENT DEVELOPMENTS TABLE 101. SENSIENT TECHNOLOGIES CORPORATION: FINANCIALS TABLE 102. SENSIENT TECHNOLOGIES CORPORATION: PRODUCTS & SERVICES TABLE 103. SENSIENT TECHNOLOGIES CORPORATION: RECENT DEVELOPMENTS
SummaryThe spirulina market refers to the market for the blue-green algae known as spirulina. Spirulina is a natural dietary supplement that is widely recognized for its nutritional value and potential health benefits. It is a rich source of protein, vitamins, minerals, antioxidants, and other bioactive compounds. The rising awareness about the health benefits of spirulina has been a major driver for its market growth. Spirulina is rich in essential nutrients, vitamins, minerals, and antioxidants, making it a popular choice among health-conscious consumers. Its potential benefits in boosting immunity, improving digestion, and supporting weight management have fueled demand for spirulina. On the other hand, the possibility of contamination may limit the spirulina market growth. Spirulina Market is likely to grow at a rate of 4.8% CAGR by 2027. Table of Contents1. Executive Summary2. Industry Outlook 2.1. Industry Overview 2.2. Industry Trends 3. Market Snapshot 3.1. Market Definition 3.2. Market Outlook 3.2.1. Porter Five Forces 3.3. Related Markets 4. Market characteristics 4.1. Market Overview 4.2. Market Segmentation 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. DRO - Impact Analysis 5. Type: Market Size & Analysis 5.1. Overview 5.2. Arthrospira Platensis 5.3. Arthrospira Maxima 6. Application: Market Size & Analysis 6.1. Overview 6.2. Nutraceuticals 6.3. Food & Beverages 6.4. Cosmetics 6.5. Animal Feed 7. Distribution Channel: Market Size & Analysis 7.1. Overview 7.2. Hospital Pharmacies 7.3. Online Providers 7.4. Drug Stores and Retail Pharmacies 8. Geography: Market Size & Analysis 8.1. Overview 8.2. North America 8.3. Europe 8.4. Asia Pacific 8.5. Rest of the World 9. Competitive Landscape 9.1. Competitor Comparison Analysis 9.2. Market Developments 9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships 9.2.2. Product Launches and execution 10. Vendor Profiles 10.1. Algenol Biofuels Inc. 10.1.1. Overview 10.1.2. Financial Overview 10.1.3. Product Offerings 10.1.4. Developments 10.1.5. Business Strategy 10.2. Cabassi & Giuriati Spa 10.2.1. Overview 10.2.2. Financial Overview 10.2.3. Product Offerings 10.2.4. Developments 10.2.5. Business Strategy 10.3. Cyanotech Corporation 10.3.1. Overview 10.3.2. Financial Overview 10.3.3. Product Offerings 10.3.4. Developments 10.3.5. Business Strategy 10.4. Ddw Inc. 10.4.1. Overview 10.4.2. Financial Overview 10.4.3. Product Offerings 10.4.4. Developments 10.4.5. Business Strategy 10.5. Dic Corporation 10.5.1. Overview 10.5.2. Financial Overview 10.5.3. Product Offerings 10.5.4. Developments 10.5.5. Business Strategy 10.6. Döhler Gmbh 10.6.1. Overview 10.6.2. Financial Overview 10.6.3. Product Offerings 10.6.4. Developments 10.6.5. Business Strategy 10.7. Dongtai City Spirulina Bio-Engineering Co, Ltd. 10.7.1. Overview 10.7.2. Financial Overview 10.7.3. Product Offerings 10.7.4. Developments 10.7.5. Business Strategy 10.8. Echlorial 10.8.1. Overview 10.8.2. Financial Overview 10.8.3. Product Offerings 10.8.4. Developments 10.8.5. Business Strategy 10.9. E.I.D. Parry Limited 10.9.1. Overview 10.9.2. Financial Overview 10.9.3. Product Offerings 10.9.4. Developments 10.9.5. Business Strategy 10.10. Givaudan International Sa 10.10.1. Overview 10.10.2. Financial Overview 10.10.3. Product Offerings 10.10.4. Developments 10.10.5. Business Strategy 10.11. Prolgae Spirulina Supplies Pvt. Ltd. 10.11.1. Overview 10.11.2. Financial Overview 10.11.3. Product Offerings 10.11.4. Developments 10.11.5. Business Strategy 10.12. Pond Technologies Inc. 10.12.1. Overview 10.12.2. Financial Overview 10.12.3. Product Offerings 10.12.4. Developments 10.12.5. Business Strategy 10.13. Sensient Technologies Corporation 10.13.1. Overview 10.13.2. Financial Overview 10.13.3. Product Offerings 10.13.4. Developments 10.13.5. Business Strategy 11. Analyst Opinion 12. Annexure 12.1. Report Scope 12.2. Market Definitions 12.3. Research Methodology 12.3.1. Data Collation and In-house Estimation 12.3.2. Market Triangulation 12.3.3. Forecasting 12.4. Report Assumptions 12.5. Declarations 12.6. Stakeholders 12.7. Abbreviations List of Tables/GraphsTABLE 1. GLOBAL SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION)TABLE 2. GLOBAL SPIRULINA MARKET VALUE FOR ARTHROSPIRA PLATENSIS, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 3. GLOBAL SPIRULINA MARKET VALUE FOR ARTHROSPIRA MAXIMA, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 4. GLOBAL SPIRULINA MARKET VALUE, BY APPLICATION, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 5. GLOBAL SPIRULINA MARKET VALUE FOR NUTRACEUTICALS, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 6. GLOBAL SPIRULINA MARKET VALUE FOR FOOD & BEVERAGES, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 7. GLOBAL SPIRULINA MARKET VALUE FOR COSMETICS, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 8. GLOBAL SPIRULINA MARKET VALUE FOR ANIMAL FEED, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 9. GLOBAL SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 10. GLOBAL SPIRULINA MARKET VALUE FOR POWDER, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 11. GLOBAL SPIRULINA MARKET VALUE FOR TABLET & CAPSULE, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 12. GLOBAL SPIRULINA MARKET VALUE FOR LIQUID, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 13. GLOBAL SPIRULINA MARKET VALUE FOR GRANULE & GELLING AGENT, BY GEOGRAPHY, 2021-2027 (USD BILLION) TABLE 14. NORTH AMERICA SPIRULINA MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION) TABLE 15. NORTH AMERICA SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 16. NORTH AMERICA SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 17. NORTH AMERICA SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 18. U.S SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 19. U.S SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 20. U.S SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 21. CANADA SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 22. CANADA SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 23. CANADA SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 24. EUROPE SPIRULINA MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION) TABLE 25. EUROPE SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 26. EUROPE SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 27. EUROPE SPIRULINA MARKET VALUE, ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 28. GERMANY SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 29. GERMANY SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 30. GERMANY SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 31. U.K SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 32. U.K SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 33. U.K SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 34. FRANCE SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 35. FRANCE SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 36. FRANCE SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 37. ITALY SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 38. ITALY SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 39. ITALY SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 40. SPAIN SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 41. SPAIN SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 42. SPAIN SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 43. ROE SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 44. ROE SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 45. ROE SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 46. ASIA PACIFC SPIRULINA MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION) TABLE 47. ASIA PACIFC SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 48. ASIA PACIFC SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 49. ASIA PACIFC SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 50. CHINA SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 51. CHINA SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 52. CHINA SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 53. INDIA SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 54. INDIA SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 55. INDIA SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 56. JAPAN SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 57. JAPAN SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 58. JAPAN SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 59. REST OF APAC SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 60. REST OF APAC SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 61. REST OF APAC SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 62. REST OF WORLD SPIRULINA MARKET VALUE, BY TYPE, 2021-2027 (USD BILLION) TABLE 63. REST OF WORLD SPIRULINA MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION) TABLE 64. REST OF WORLD SPIRULINA MARKET VALUE, BY ROUTE FORMULATION, 2021-2027 (USD BILLION) TABLE 65. ALGENOL BIOFUELS INC.: FINANCIALS TABLE 66. ALGENOL BIOFUELS INC.: PRODUCTS & SERVICES TABLE 67. ALGENOL BIOFUELS INC.: RECENT DEVELOPMENTS TABLE 68. CABASSI & GIURIATI SPA: FINANCIALS TABLE 69. CABASSI & GIURIATI SPA: PRODUCTS & SERVICES TABLE 70. CABASSI & GIURIATI SPA: RECENT DEVELOPMENTS TABLE 71. CYANOTECH CORPORATION: FINANCIALS TABLE 72. CYANOTECH CORPORATION: PRODUCTS & SERVICES TABLE 73. CYANOTECH CORPORATION: RECENT DEVELOPMENTS TABLE 74. DDW INC.: FINANCIALS TABLE 75. DDW INC.: PRODUCTS & SERVICES TABLE 76. DDW INC.: RECENT DEVELOPMENTS TABLE 77. DIC CORPORATION: FINANCIALS TABLE 78. DIC CORPORATION: PRODUCTS & SERVICES TABLE 79. DIC CORPORATION: RECENT DEVELOPMENTS TABLE 80. DÖHLER GMBH: FINANCIALS TABLE 81. DÖHLER GMBH: PRODUCTS & SERVICES TABLE 82. DÖHLER GMBH: RECENT DEVELOPMENTS TABLE 83. DONGTAI CITY SPIRULINA BIO-ENGINEERING CO, LTD.: FINANCIALS TABLE 84. DONGTAI CITY SPIRULINA BIO-ENGINEERING CO, LTD.: PRODUCTS & SERVICES TABLE 85. DONGTAI CITY SPIRULINA BIO-ENGINEERING CO, LTD.: RECENT DEVELOPMENTS TABLE 86. ECHLORIAL: FINANCIALS TABLE 87. ECHLORIAL: PRODUCTS & SERVICES TABLE 88. ECHLORIAL: RECENT DEVELOPMENTS TABLE 89. E.I.D. PARRY LIMITED: FINANCIALS TABLE 90. E.I.D. PARRY LIMITED: PRODUCTS & SERVICES TABLE 91. E.I.D. PARRY LIMITED: RECENT DEVELOPMENTS TABLE 92. GIVAUDAN INTERNATIONAL SA: FINANCIALS TABLE 93. GIVAUDAN INTERNATIONAL SA: PRODUCTS & SERVICES TABLE 94. GIVAUDAN INTERNATIONAL SA: RECENT DEVELOPMENTS TABLE 95. PROLGAE SPIRULINA SUPPLIES PVT. LTD.: FINANCIALS TABLE 96. PROLGAE SPIRULINA SUPPLIES PVT. LTD.: PRODUCTS & SERVICES TABLE 97. PROLGAE SPIRULINA SUPPLIES PVT. LTD.: RECENT DEVELOPMENTS TABLE 98. POND TECHNOLOGIES INC.: FINANCIALS TABLE 99. POND TECHNOLOGIES INC.: PRODUCTS & SERVICES TABLE 100. POND TECHNOLOGIES INC.: RECENT DEVELOPMENTS TABLE 101. SENSIENT TECHNOLOGIES CORPORATION: FINANCIALS TABLE 102. SENSIENT TECHNOLOGIES CORPORATION: PRODUCTS & SERVICES TABLE 103. SENSIENT TECHNOLOGIES CORPORATION: RECENT DEVELOPMENTS
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
IHR Insights社の医療分野での最新刊レポート
本レポートと同じKEY WORD(nutraceuticals)の最新刊レポート
よくあるご質問IHR Insights社はどのような調査会社ですか?IHR InsightsはICT、化学品、ヘルスケア、半導体など、世界の幅広い分野を対象に調査し、専門的な知識を基に市場調査報告書を出版しています。 主な調査分野 ◇ICT ◇化学品、材料、... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|